Advanced search
Publication Cover
Clinical Research Practices and Drug Regulatory Affairs Volume 3, 1985 - Issue 1
Journal homepage
5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Drug Abuse Control and the Pharmacist's Role in the Legislative Decision-Making Process

Edward H. Clouse Assistant Professor, Pharmacy Administration, College of Pharmacy, Idaho State University, Pocatello, Idaho, 83209
,
Richard A. Angorn Associate Professor, Pharmacy Health Care Administration, College of Pharmacy, University of Florida, Gainesville, Florida, 32610
&
Barry A. Bleidt Assistant Professor of Pharmacy Administration, College of Pharmacy & Allied Health Professions, Northeastern University, Boston, Massachusetts, 02115
Pages 71-81 | Published online: 28 Sep 2008

References

  • Bleidt B. A. Implementation of a Pharmacist/Physician Initiated Voluntary Program to Curb Amphetamine and Methaqualone Abuse. University of Florida, Gainesville 1982
  • California Health and Safety Code, sec. 11164. 1983
  • Dans P. E. “Physicians and Health Policy,”. J. Amer. Med. Assoc 1980; 243: 1451
  • Delaware Uniform Controlled Substances Regs., reg. 4. h. 1983
  • Drug Abuse Control Amendments, 21 U.S.C. sec. 360.
  • Edwards George C. III. Implementing Public Policy. Congressional Quarterly Press, Washington, D.C. 1980
  • Federal Register. 1972; Vol. 37: 10374, No. 99, pg.
  • FDA Drug Bulletin. 1979; Vol. 9: 24, No. 4, pg.
  • Florida Leg. Sess. 1980; 256, S., H.R. 349(.
  • Florida Stat. (Supp. 1982, sec. 458.331 (q).
  • Florida Stat. (Supp. 1982, secs. 458–331 (cc), 459.015 (cc).
  • , Harrison Narcotic Act, 21 U.S.C. sec. 4701.
  • 1982, Idaho Code, sec. 37–2722
  • 1984, Illinois Rev. Stat., ch. 56 1/2, sec. 1308
  • 1980, New York Pub. Health (McKinney), sec. 3333
  • 1982, Pub. L. No. 91–513, 84 Stat. 1236
  • 1982, Texas Drug Laws, sec. 3.09
  • Vogt Donald, Montagne Michael. “The Process of Drug Development: I. The Historical Interplay of Political Economics, Research and Regulation,”. Clin. Res. Practices & Drug Reg. Affairs 1983; 1: 1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.